Clinical trial · Observational
Multiple Myeloma (MM) Quality of Life (QOL) Study
Quality of Life and Psychological Distress in Patients With Multiple Myeloma and Their Caregivers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The main purpose of this study is to examine differences in quality of life and psychological distress for both Multiple Myeloma patients receiving treatment and their caregivers and to assess patient and caregiver prognostic understanding (understanding of the likely course of a disease over time) of Multiple Myeloma to guide development of more personalized treatment plans. This study looks to further understand quality of life changes throughout multiple myeloma therapy for both patients and caregivers to help determine ways to improve patient and caregiver understanding of illness and in turn, tailor customized treatment that best aligns with patient preferences. The study will use a series of questionnaires to measure quality of life, mood, coping strategies, and prognostic understanding.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
| Quality of Life | — | UNRESOLVED | — |
| Symptom, Behavioral | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaire | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Newly Diagnosed MM 1st Line and Caregivers
- description
- This research study's procedures include screening for eligibility, participant designation of a caregiver and a series of questionnaires. * Patients will be asked to identify a caregiver (e.g. a relative or friend) upon whom they rely for help and has an in-person contact with the patient at least 2x per week. * Both patients with or without identified caregivers will complete a one time series of questionnaires. * The questionnaires are completed one time only and measure quality of life, mood, coping strategies, and prognostic understanding and can be completed in the hospital, clinic, over the email, or telephone with assistance provided as needed.Questionnaires take approximately 20 minutes to complete.
- interventionNames
- Behavioral: Questionnaire
- label
- MM receiving 1-3 prior lines of therapy and Caregivers
- description
- This research study's procedures include screening for eligibility, participant designation of a caregiver and a series of questionnaires. * Patients will be asked to identify a caregiver (e.g. a relative or friend) upon whom they rely for help and has an in-person contact with the patient at least 2x per week. * Both patients with or without identified caregivers will complete a one time series of questionnaires. * The questionnaires are completed one time only and measure quality of life, mood, coping strategies, and prognostic understanding and can be completed in the hospital, clinic, over the email, or telephone with assistance provided as needed.Questionnaires take approximately 20 minutes to complete
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patient Eligibility criteria: * Adult patients (greater than 18 years) receiving active therapy for MM. * For patients with newly diagnosed MM, patients are eligible while undergoing induction therapy prior to received autologous stem cell transplant but not after. * Ability to read questions in English or willing to complete questionnaires with the assistance of an interpreter. Caregiver Eligibility criteria: * Adult (greater than 18 years) relative or a friend of a patient who agrees to participate in the study whom the patient identified as living with them or having in-person contact with him or her at least twice per week. * Ability to read and respond to questions in English or to complete questionnaires with minimal assistance of an interpreter Exclusion Criteria: * Patient Exclusion criteria: * Patients receiving maintenance therapy only. * Significant psychiatric or other co-morbid disease, which the treating clinician believes prohibits informed consent or participation in the study.
References
Publications (0)
Data not yet available